SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-296695
Filing Date
2019-11-20
Accepted
2019-11-20 17:22:36
Documents
9
Effectiveness Date
2019-11-20

Document Format Files

Seq Description Document Type Size
1 S-8 d804278ds8.htm S-8 65755
2 EX-5.1 d804278dex51.htm EX-5.1 5777
3 EX-23.1 d804278dex231.htm EX-23.1 1369
4 EX-23.2 d804278dex232.htm EX-23.2 1258
5 EX-99.1 d804278dex991.htm EX-99.1 68649
6 EX-99.2 d804278dex992.htm EX-99.2 22489
7 EX-99.3 d804278dex993.htm EX-99.3 30131
8 EX-99.4 d804278dex994.htm EX-99.4 21519
9 GRAPHIC g804278g33o70.jpg GRAPHIC 2688
  Complete submission text file 0001193125-19-296695.txt   221858
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-234803 | Film No.: 191235124
SIC: 2834 Pharmaceutical Preparations